ChemDiv to Provide Schering Plough Corporation with Discovery Libraries in Multiyear Agreement
News Jun 06, 2008
ChemDiv announced today the continuation of multi-year collaboration with Schering Plough Corporation. In the framework of this collaboration ChemDiv will provide Schering Plough with a set of chemical libraries that will be produced through parallel synthesis based on the customer selected templates.
In accordance with the agreement teams of ChemDiv and Schering Plough scientists will work closely to develop exclusive small molecule libraries enhancing Schering Plough's global drug discovery effort. Further details and financial terms were not disclosed.
"ChemDiv is excited to be working with Schering Plough a pioneer of pharmaceutical industry that is working to improve people's health and extend lives. Their decision to select ChemDiv as their drug discovery partner underscores the quality of our work, the innovation we bring to our partners and our solid reputation for success in this field," said Nikolay Savchuk, President and CEO of ChemDiv.
"We are committed to expanding our product line to provide more integrated drug discovery services to our clients. We are now engaged in more discovery research programs than ever before, and we look forward to generating value on behalf of our clients."
Tuberculosis (TB), an ancient and notoriously difficult disease to treat, has killed millions through the course of human history; and the antibiotics that have been used to fight the disease in recent history are becoming less and less effective. In the face of this reality, researcher Prof. Dennis Wright has improved upon a new way to thwart the tricky pathogen, mycobacterium tuberculosis.READ MORE
Researchers have solved the structures of the cancer-promoting enzymes USP25 and USP28, and identified significant differences in their activities. This knowledge provides the molecular basis for the development of new and highly specific anti-cancer drugs, with a low risk of side-effects.READ MORE